D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 43 Citations 7,312 77 World Ranking 4123 National Ranking 1615

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Bacteria
  • Antibiotics

Microbiology, Caspofungin, Candida albicans, Echinocandin and Corpus albicans are his primary areas of study. His Microbiology study incorporates themes from Anidulafungin and Mutant. His Anidulafungin research is multidisciplinary, incorporating perspectives in Multilocus sequence typing, Fungal protein and Caspofungin Acetate.

The Mutant study combines topics in areas such as Candida glabrata, Echinocandins and Candida krusei. His study in Candida albicans focuses on Antifungal drug in particular. His research in Aspergillus fumigatus intersects with topics in Aspergillosis and Aspergillus.

His most cited work include:

  • Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates (320 citations)
  • Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-d-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint (241 citations)
  • High-frequency Triazole Resistance Found In Nonculturable Aspergillus fumigatus from Lungs of Patients with Chronic Fungal Disease (237 citations)

What are the main themes of his work throughout his whole career to date?

Steven Park mostly deals with Microbiology, Aspergillus fumigatus, Candida albicans, Echinocandin and Caspofungin. Steven Park has included themes like Mutant, Fungal protein and Micafungin in his Microbiology study. His study on Aspergillus fumigatus also encompasses disciplines like

  • Aspergillosis and Nucleic acid most often made with reference to Aspergillus,
  • Genotyping and Molecular probe most often made with reference to Molecular biology.

His biological study spans a wide range of topics, including Fungi imperfecti and Ergosterol. His Echinocandin research integrates issues from Anidulafungin and Biochemistry. Steven Park interconnects Antifungal drug and Staphylococcus aureus in the investigation of issues within Drug resistance.

He most often published in these fields:

  • Microbiology (67.95%)
  • Aspergillus fumigatus (28.21%)
  • Candida albicans (26.92%)

What were the highlights of his more recent work (between 2014-2020)?

  • Microbiology (67.95%)
  • Antibiotics (6.41%)
  • Tuberculosis (3.85%)

In recent papers he was focusing on the following fields of study:

Steven Park focuses on Microbiology, Antibiotics, Tuberculosis, Pharmacokinetics and Pathology. Steven Park specializes in Microbiology, namely Drug resistance. His work on Multiple drug resistance as part of general Drug resistance study is frequently linked to Bacterial genetics, bridging the gap between disciplines.

His Antibiotics research is multidisciplinary, incorporating elements of Natural product and Bacteria. His research on Tuberculosis also deals with topics like

  • In vivo, which have a strong connection to Multidrug-Resistant Mycobacterium tuberculosis, Antimicrobial, Virulence factor and Lesion,
  • Potency which intersects with area such as Drug and Ethambutol. His work in Pathology covers topics such as Aspergillosis which are related to areas like Aspergillus and Caspofungin.

Between 2014 and 2020, his most popular works were:

  • Culture-independent discovery of the malacidins as calcium-dependent antibiotics with activity against multidrug-resistant Gram-positive pathogens. (147 citations)
  • Discovery of MRSA active antibiotics using primary sequence from the human microbiome (67 citations)
  • Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy. (33 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Bacteria
  • Antibiotics

His scientific interests lie mostly in Bacteria, Microbiology, Antibiotics, Microbiome and Tuberculosis. His studies in Bacteria integrate themes in fields like Gene expression, Gene, Lipid II, Human microbiome and Natural product. His study brings together the fields of Nonribosomal peptide and Microbiology.

His study in Microbiome is interdisciplinary in nature, drawing from both Medical microbiology, Multiple drug resistance, Drug resistance and Staphylococcus aureus. His Tuberculosis research includes themes of Pharmacokinetics and Potency. Steven Park has researched Pathology in several fields, including In vivo and Drug.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates

S. Park;R. Kelly;J. Nielsen Kahn;J. Robles.
Antimicrobial Agents and Chemotherapy (2005)

458 Citations

A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.

Guillermo Garcia-Effron;Santosh K. Katiyar;Steven Park;Thomas D. Edlind.
Antimicrobial Agents and Chemotherapy (2008)

361 Citations

High-frequency Triazole Resistance Found In Nonculturable Aspergillus fumigatus from Lungs of Patients with Chronic Fungal Disease

David W. Denning;Steven Park;Cornelia Lass-Florl;Marcin G. Fraczek;Marcin G. Fraczek.
Clinical Infectious Diseases (2011)

342 Citations

Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-d-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint

Guillermo Garcia-Effron;Samuel Lee;Steven Park;John D. Cleary.
Antimicrobial Agents and Chemotherapy (2009)

313 Citations

Multiple Resistance Mechanisms among Aspergillus fumigatus Mutants with High-Level Resistance to Itraconazole

Adriana M. Nascimento;Gustavo H. Goldman;Steven Park;Salvatore A. E. Marras.
Antimicrobial Agents and Chemotherapy (2003)

295 Citations

Culture-independent discovery of the malacidins as calcium-dependent antibiotics with activity against multidrug-resistant Gram-positive pathogens.

Bradley M. Hover;Seong Hwan Kim;Micah Katz;Zachary Charlop-Powers.
Nature microbiology (2018)

279 Citations

Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints.

Guillermo Garcia-Effron;Steven Park;David S. Perlin.
Antimicrobial Agents and Chemotherapy (2009)

271 Citations

Assessing Resistance to the Echinocandin Antifungal Drug Caspofungin in Candida albicans by Profiling Mutations in FKS1

Sergey V. Balashov;Steven Park;David S. Perlin;David S. Perlin.
Antimicrobial Agents and Chemotherapy (2006)

252 Citations

Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis

Michel Laverdière;Richard G. Lalonde;Jean Guy Baril;Donald C. Sheppard.
Journal of Antimicrobial Chemotherapy (2006)

247 Citations

Multi-azole resistance in Aspergillus fumigatus

Susan J. Howard;Ian Webster;Caroline B. Moore;Rebecca E. Gardiner.
International Journal of Antimicrobial Agents (2006)

231 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Steven Park

David S. Perlin

David S. Perlin

Rutgers, The State University of New Jersey

Publications: 105

David W. Denning

David W. Denning

University of Manchester

Publications: 75

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 64

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 57

Willem J. G. Melchers

Willem J. G. Melchers

Radboud University Nijmegen

Publications: 46

Michael A. Pfaller

Michael A. Pfaller

JMI Laboratories

Publications: 42

Manuel Cuenca-Estrella

Manuel Cuenca-Estrella

Instituto de Salud Carlos III

Publications: 38

Daniel J. Diekema

Daniel J. Diekema

University of Iowa Hospitals and Clinics

Publications: 38

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 33

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 33

William J. Steinbach

William J. Steinbach

Duke University

Publications: 30

Nathan P. Wiederhold

Nathan P. Wiederhold

The University of Texas Health Science Center at San Antonio

Publications: 29

Emilia Mellado

Emilia Mellado

Instituto de Salud Carlos III

Publications: 28

Maurizio Sanguinetti

Maurizio Sanguinetti

Catholic University of the Sacred Heart

Publications: 27

Jesús Guinea

Jesús Guinea

Hospital General Universitario Gregorio Marañón

Publications: 26

Joseph Meletiadis

Joseph Meletiadis

National and Kapodistrian University of Athens

Publications: 26

Trending Scientists

Junshan Zhang

Junshan Zhang

Arizona State University

Jian Zhang

Jian Zhang

University of Technology Sydney

Sunderesh S. Heragu

Sunderesh S. Heragu

Oklahoma State University

Dapeng Cao

Dapeng Cao

Beijing University of Chemical Technology

Hadi Quesneville

Hadi Quesneville

University of Paris-Saclay

Lalji Singh

Lalji Singh

Centre for Cellular and Molecular Biology

Isabel Palomera

Isabel Palomera

Spanish National Research Council

Serge Morand

Serge Morand

Centre national de la recherche scientifique, CNRS

Volker Erfle

Volker Erfle

Technical University of Munich

J. Scott Weese

J. Scott Weese

University of Guelph

Rebecca H. Buckley

Rebecca H. Buckley

Duke University

Shane J. Lopez

Shane J. Lopez

University of Kansas

Andrew M. Prentice

Andrew M. Prentice

London School of Hygiene & Tropical Medicine

Andrew Georgiou

Andrew Georgiou

Macquarie University

Alberto Amaral

Alberto Amaral

University of Porto

John Collins

John Collins

University of Minnesota

Something went wrong. Please try again later.